Supplementary Figures from Tumor Subtype Determines Therapeutic Response to Chimeric Polypeptide Nanoparticle–based Chemotherapy in <i>Pten</i>-deleted Mouse Models of Sarcoma
Publication
, Other
Dodd, RD; Scherer, A; Huang, W; McGivney, GR; Gutierrez, WR; Laverty, EA; Ashcraft, KA; Stephens, VR; Yousefpour, P; Saha, S; Knepper-Adrian, V ...
March 31, 2023
Duke Scholars
Citation
APA
Chicago
ICMJE
MLA
NLM
Dodd, R. D., Scherer, A., Huang, W., McGivney, G. R., Gutierrez, W. R., Laverty, E. A., … Kirsch, D. G. (2023). Supplementary Figures from Tumor Subtype Determines Therapeutic Response to Chimeric Polypeptide Nanoparticle–based Chemotherapy in <i>Pten</i>-deleted Mouse Models of Sarcoma. https://doi.org/10.1158/1078-0432.22475132
Dodd, Rebecca D., Amanda Scherer, Wesley Huang, Gavin R. McGivney, Wade R. Gutierrez, Emily A. Laverty, Kathleen A. Ashcraft, et al. “Supplementary Figures from Tumor Subtype Determines Therapeutic Response to Chimeric Polypeptide Nanoparticle–based Chemotherapy in <i>Pten</i>-deleted Mouse Models of Sarcoma,” March 31, 2023. https://doi.org/10.1158/1078-0432.22475132.
Dodd RD, Scherer A, Huang W, McGivney GR, Gutierrez WR, Laverty EA, et al. Supplementary Figures from Tumor Subtype Determines Therapeutic Response to Chimeric Polypeptide Nanoparticle–based Chemotherapy in <i>Pten</i>-deleted Mouse Models of Sarcoma. 2023.
Dodd, Rebecca D., et al. Supplementary Figures from Tumor Subtype Determines Therapeutic Response to Chimeric Polypeptide Nanoparticle–based Chemotherapy in <i>Pten</i>-deleted Mouse Models of Sarcoma. 31 Mar. 2023. Crossref, doi:10.1158/1078-0432.22475132.
Dodd RD, Scherer A, Huang W, McGivney GR, Gutierrez WR, Laverty EA, Ashcraft KA, Stephens VR, Yousefpour P, Saha S, Knepper-Adrian V, Floyd W, Chen M, Ma Y, Mastria EM, Cardona DM, Eward WC, Chilkoti A, Kirsch DG. Supplementary Figures from Tumor Subtype Determines Therapeutic Response to Chimeric Polypeptide Nanoparticle–based Chemotherapy in <i>Pten</i>-deleted Mouse Models of Sarcoma. 2023.